IP Library Granted Patent US 8,575,358
Granted Patent B2
US 8,575,358 · App. 13/410,405 · Granted Nov 5, 2013

Oxazolidinium compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,575,358
App. No.
13/410,405
Granted
Nov 5, 2013
Kind
B2
Abstract

Oxazolidinium compounds are formed by the reaction of a halohydrin or an epoxide with a secondary amine and an aldehyde or a ketone. The oxazolidinium compounds are formed directly and do not require the reaction of a pre-formed oxazolidine with an alkylating agent. The compounds are useful as gas hydrate inhibitors in oil and gas production and transportation. The oxazolidinium compounds have the structure: where R is a saturated or unsaturated alkyl group containing from 3 to 20 carbon atoms, where R has an absence of aryl groups; R 1 and R 2 each independently have 1 to 20 carbon atoms, may be linear, branched or cyclic; linear, branched or cyclic groups having 1 to 20 carbon atoms substituted with alkyl groups, aryl groups, alkylaryl groups, and aryl groups substituted with alkoxy groups, and X is selected from the group consisting of chlorine, fluorine, bromine or iodine.

Claims (10)

1. An oxazolidinium compound having the structure:

where R is a saturated or unsaturated alkyl group containing from 3 to 20 carbon atoms, where R has an absence of aryl groups; R 1 and R 2 each independently have 1 to 20 carbon atoms, may be linear, branched or cyclic; linear, branched or cyclic groups having 1 to 20 carbon atoms substituted with alkyl groups, aryl groups, alkylaryl groups, and aryl groups substituted with alkoxy groups, and X is selected from the group consisting of chlorine, fluorine, bromine or iodine.

2. The oxazolidinium compound of claim 1 where R contains from 4 to 16 carbon atoms.

3. The oxazolidinium compound of claim 1 where R 1 and R 2 each independently have from 2 to 6 carbon atoms.

4. The oxazolidinium compound of claim 1 where R 1 and R 2 each independently have from 2 to 5 carbon atoms.

5. The oxazolidinium compound of claim 1 where R 1 and R 2 each independently have from 3 to 5 carbon atoms.

6. An oxazolidinium compound having the structure:

where R is a saturated or unsaturated alkyl group containing from 4 to 16 carbon atoms, where R has an absence of aryl groups; R 1 and R 2 each independently have 2 to 6 carbon atoms, may be linear, branched or cyclic; linear, branched or cyclic groups having 1 to 20 carbon atoms substituted with alkyl groups, aryl groups, alkylaryl groups, and aryl groups substituted with alkoxy groups, and X is selected from the group consisting of chlorine, fluorine, bromine or iodine.

7. The oxazolidinium compound of claim 6 where R 1 and R 2 each independently have from 2 to 5 carbon atoms.

8. The oxazolidinium compound of claim 6 where R 1 and R 2 each independently have from 3 to 5 carbon atoms.

Assignments (3)
CHANGE OF NAME Recorded Mar 8, 2022
From: BAKER HUGHES, A GE COMPANY, LLC
To: BAKER HUGHES HOLDINGS LLC
Reel/Frame 059337/0928 →
CHANGE OF NAME Recorded Feb 16, 2022
From: BAKER HUGHES INCORPORATED
To: BAKER HUGHES, A GE COMPANY, LLC
Reel/Frame 059126/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2012
From: RIVERS, GORDON T.; TIAN, JUN; HACKEROTT, JAMES A.
To: BAKER HUGHES INCORPORATED
Reel/Frame 027896/0342 →